Werewolf Therapeutics Inc. Annual stock financials by MarketWatch. View the latest HOWL financial statements, income statements and financial ratios.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Werewolf Therapeutics (HOWL – Research Report), Oric Pharmaceuticals (ORIC – Research Report) and Acadia ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Fintel reports that on May 12, 2023, B of A Securities maintained coverage of Werewolf Therapeutics (NASDAQ:HOWL) with a Buy recommendation. As of May 11, 2023, the average one-year price target for ...

On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline update in which it highlighted clinical progress and 2026 priorities for its INDUKINE programs and ...